Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy (Q37247110)

19 August 2017

1 reference

title

Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy (English)

1 reference

19 August 2017

main subject

Gram-negative bacteria

0 references

antibiotic resistance

1 reference

David L Paterson

1

0 references

language of work or name

English

0 references

publication date

1 September 2008

1 reference

Clinical Infectious Diseases

19 August 2017

published in

1 reference

19 August 2017

volume

47 Suppl 1

1 reference

19 August 2017

page(s)

S14-20

1 reference

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

19 August 2017

cites work

1 reference

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

21 January 2018

1 reference

Global challenge of multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

A step closer to extreme drug resistance (XDR) in gram-negative bacilli

21 January 2018

1 reference

Trends in antimicrobial drug development: implications for the future

21 January 2018

1 reference

Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit

21 January 2018

1 reference

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

21 January 2018

1 reference

Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli

21 January 2018

1 reference

Evaluating treatment protocols to prevent antibiotic resistance

21 January 2018

1 reference

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

21 January 2018

1 reference

Surveillance studies: how can they help the management of infection?

21 January 2018

1 reference

Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial.

21 January 2018

1 reference

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

21 January 2018

1 reference

Practice guidelines for the management of bacterial meningitis

21 January 2018

1 reference

Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

21 January 2018

1 reference

Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?

21 January 2018

1 reference

Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy.

21 January 2018

1 reference

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram

21 January 2018

1 reference

Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms

21 January 2018

1 reference

Meropenem administered as a prolonged infusion to treat serious gram-negative central nervous system infections

21 January 2018

1 reference

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

21 January 2018

1 reference

Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli

21 January 2018

1 reference

Direct E-test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia.

21 January 2018

1 reference

New diagnostic tools for neonatal sepsis: the role of a real-time polymerase chain reaction for the early detection and identification of bacterial and fungal species in blood samples.

21 January 2018

1 reference

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections

21 January 2018

1 reference

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline

21 January 2018

1 reference

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/590062

1 reference

19 August 2017

1 reference